penpulimab

  • Purchase Qty: 1
  • Unit: g(s)
  • Fob Unit Price: US $100
  • Payment Terms:L/C , T/T , D/P , PayPal
  • Favorite
Hangzhou ROYALL Import & Export Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

  • Active Ingredients:Penpulimab
  • Assay:98
  • Pharmacopeia:CP
  • Package Type:Drum & plastic bags, Aluminum foiled bag, Zip lock bags 
  • Shelf Life:18 months
  • Storage:Sealed
  • Place of Origin:China (Mainland)

Description

Penpulimab-kcqx is ahumanized IgG1 monoclonal antibody and programmed cell death protein 1 (PD-1) inhibitordeveloped by Akeso, Inc.Medical Indications and Approvals
  • Nasopharyngeal Carcinoma (NPC): Approved by the U.S. FDA in April 2025 as penpulimab-kcqx for adult non-keratinizing nasopharyngeal carcinoma in two main settings:
    • First-line treatment: Given intravenously in combination with cisplatin or carboplatin and gemcitabine for recurrent or metastatic disease.
    • Single-agent treatment: Used alone for metastatic disease that has progressed following platinum-based chemotherapy and at least one other prior line of therapy. 
  • International Status: Also approved in China (marketed under the brand name Anike) for recurrent or metastatic nasopharyngeal carcinoma and locally advanced/metastatic squamous non-small cell lung cancer.


You Might Also Like
Change a group
Inquiry Cart(0)